Fingerprint
Dive into the research topics of 'Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Measurable residual disease does not preclude prolonged progression-free survival in CLL treated with ibrutinib
Xin Victoria Wang, Curtis A. Hanson, Renee C. Tschumper, Connie E. Lesnick, Esteban Braggio, Elisabeth M. Paietta, Susan O'Brien, Jacqueline C. Barrientos, Jose Francisco Leis, Cong Christine Zhang, Steven E. Coutre, Paul M. Barr, Amanda F. Cashen, Anthony R. Mato, Avina K. Singh, Michael P. Mullane, Harry Erba, Richard Stone, Mark R. Litzow, Martin S. Tallman
Research output: Contribution to journal › Article › peer-review
19
Scopus
citations